Dr Samantha Grimley
Research Officer
Department of Microbiology and Immunology
24 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
Preclinical development of a cross-protective β-SARS-CoV-2 virus-like particle vaccine adjuvanted with MF59
DOI: 10.1038/s41541-025-01355-y2026
Journal article
Common Acquisition of Broadly Neutralizing Antibodies in an HTLV-1c First Nations Cohort from Central Australia
DOI: 10.3390/v180404022025
Journal article
Air–Liquid-Interface-Differentiated Human Nose Epithelium: The Benchmark Culture Model for SARS-CoV-2 Infection
DOI: 10.3390/organoids40300212025
Book Chapter
Polarized Calu-3 Cells Serve as an Intermediary Model for SARS-CoV-2 Infection.
DOI: 10.1007/7651_2024_6022024
Journal article
mRNA vaccines encoding membrane-anchored RBDs of SARS-CoV-2 mutants induce strong humoral responses and can overcome immune imprinting
DOI: 10.1016/j.omtm.2024.1013802024
Journal article
Uncovering strain- and age-dependent innate immune responses to SARS-CoV-2 infection in air-liquid-interface cultured nasal epithelia
DOI: 10.1016/j.isci.2024.1100092018
Research Contracts
Antibody-Based HIV Prevention
RECENT SCHOLARLY WORKS
2024
Journal article
Human Nasal Epithelium Organoids for Assessing Neutralizing Antibodies to a Protective SARS-CoV-2 Virus-like Particle Vaccine
DOI: 10.3390/organoids30100022023
Journal article
377. Phase I trial of two novel SARS-CoV-2 beta variant receptor-binding domain recombinant protein and mRNA vaccines as 4th dose boosters
DOI: 10.1093/ofid/ofad500.4472023
Journal article
SARS-CoV-2 mouse adaptation selects virulence mutations that cause TNF-driven age-dependent severe disease with human correlates
DOI: 10.1073/pnas.23016891202023
Journal article
Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
DOI: 10.1016/j.ebiom.2023.104574
RECENT PROJECTS
2021
Research Grant
Isolation of Human Neutralising Monoclonal Antibodies for the Prevention of HTLV-1c Transmission
2019
Research Contracts
Salary Contribution - Advance HTLV-1c Biomedical Prevention Strategies' Research Project